Publicaciones (28) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

    Neurobiology of Disease, Vol. 20, Núm. 3, pp. 814-822

  2. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

  3. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array

    Genes Chromosomes and Cancer, Vol. 42, Núm. 3, pp. 287-298

  4. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: Results from the Dallas Heart Study

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, Núm. 10, pp. 2192-2196

  5. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26

  6. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies

    Leukemia, Vol. 19, Núm. 2, pp. 245-252

  7. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products

    Diabetes and Vascular Disease Research, Vol. 2, Núm. 2, pp. 81-87

  8. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome

    Human Genetics, Vol. 116, Núm. 6, pp. 476-485

  9. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)

    Blood, Vol. 105, Núm. 12, pp. 4849-4852

  10. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes

    Haematologica, Vol. 90, Núm. 9, pp. 1168-1178

  11. Indoleamine 2,3-dioxygenase: From tolerance during pregnancy to cancer

    Inmunologia, Vol. 24, Núm. 4, pp. 20-27

  12. Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3′-azido-3′- deoxythymidine with nonnucleoside inhibitors

    Biochemistry, Vol. 44, Núm. 9, pp. 3535-3546

  13. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

  14. Linking two immuno-suppressive molecules: Indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression

    Biology of Reproduction, Vol. 73, Núm. 3, pp. 571-578

  15. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Nature Genetics, Vol. 37, Núm. 4, pp. 391-400

  16. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, Núm. 7, pp. 1452-1457

  17. NADPH oxidase-mediated oxidative stress: Genetic studies of the p22 phox gene in hypertension

    Antioxidants and Redox Signaling, Vol. 7, Núm. 9-10, pp. 1327-1336

  18. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2

    Cancer Genetics and Cytogenetics, Vol. 157, Núm. 2, pp. 151-156

  19. Neurohormonas y citocinas en la insuficiencia cardíaca. Correlación con la reserva de flujo coronario

    Revista Espanola de Cardiologia, Vol. 58, Núm. 11, pp. 1273-1277

  20. Pediatric meningosarcoma: Clinical evolution and genetic instability

    Pediatric Neurology, Vol. 32, Núm. 5, pp. 352-354